Order results by:
| Issue | Title | |
| Vol 15 (2023): (Suppl. 1) | Contribution of B-lymphocytes to the production of Interleukin-17 in multiple sclerosis | Abstract similar documents |
| N. V. Sursyakova, E. M. Kuklina, T. V. Baidina, I. V. Nekrasova, T. N. Trushnikova | ||
| "... . The concentrations of IL-17A, IL-10, BAFF and total IgG were analyzed in blood serum by ELISA. The additional study ..." | ||
| Vol 12, No 1 (2020) | Association of BAFF gene polymorphisms with multiple sclerosis progression | Abstract PDF (Eng) similar documents |
| I. V. Smagina, S. A. Elchaninova, A. S. Palashchenko | ||
| "... The cytokine of the tumor necrosis factor (TNF) family B-cell activating factor (BAFF) (TNFSF13B ..." | ||
| Vol 13, No 4 (2021) | Anti-B-cell therapy in patients with neuromyelitis optica spectrum disorders | Abstract PDF (Eng) similar documents |
| S. V. Kotov, E. S. Novikova, A. S. Kotov | ||
| "... to aquaporin-4 (AQP4-IgG). However, AQP4-IgG is not detected in at least 10-20% of patients with NMOSDs ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Experience with cladribine tablets for highly active multiple sclerosis in everyday clinical practice | Abstract similar documents |
| S. V. Petrov, O. V. Boyko, A. N. Boyko | ||
| "... blood analysis, lymphocyte subpopulation estimation, biochemical blood analysis. The levels ..." | ||
| Vol 7, No 2 (2015) | Hypertrophic pachymeningitis: Current criteria for diagnosis and differentiation (Clinical case and review of literature) | Abstract similar documents |
| E. G. Mendelevich, C. S. Fattakhova, E. I. Bogdanov | ||
| Vol 17, No 3 (2025) | Switching from ocrelizumab to ofatumumab: key potential reasons based on real-world clinical practice | Abstract similar documents |
| A. N. Boyko, T. O. Simaniv, T. A. Prokopyeva, S. V. Petrov, M. V. Melnikov | ||
| "... agents are monoclonal antibodies (mAbs) targeting the CD20 receptor on lymphocytes: ocrelizumab ..." | ||
| Vol 15 (2023): (Suppl. 1) | Prolonged observation after the use of cladribine in multiple sclerosis: efficacy and safety | Abstract similar documents |
| A. D. Kukushkina, A. N. Boyko | ||
| "... are a selective, highly effective oral form of IRT for MS patients with exacerbations that targets lymphocytes ..." | ||
| Vol 16, No 3 (2024) | Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra | Abstract similar documents |
| A. A. Sokolova, L. I. Anischenko, L. S. Zemlyanushin, E. A. Rubtsova | ||
| "... Scale (EDSS), complete blood count, monitoring of blood lymphocytes level and biochemical blood testing ..." | ||
| Vol 12, No 5 (2020) | The positive and negative effects of using transdermal nonsteroidal anti-inflammatory drugs: chemoreactome analysis | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, T. R. Grishina, V. A. Semenov | ||
| "... in the muscles and skin and, to a much lesser extent, in heart tissues, lymphocytes, gonads, and cartilage ..." | ||
| Vol 15, No 4 (2023) | Pharmaconutraceutical Chondroguard®TRIO – chondroprotector with immunomodulatory activity | Abstract similar documents |
| O. A. Shavlovskaya, Yu. D. Yukhnovskaya, I. D. Romanov, I. A. Bokova | ||
| "... 's patches of the small intestine, leads to the activation of immune cells (T-lymphocytes) and initiation ..." | ||
| Vol 16, No 5 (2024) | Efficacy and safety of cladribine tablets in multiple sclerosis in real-world clinical practice | Abstract similar documents |
| A. N. Peshkin, S. V. Kotov, G. T. Toniya, M. V. Sutormin, A. F. Eltayoury | ||
| "... Cladribine has a well-defined activity against lymphocytes, leading to their selective depletion ..." | ||
| Vol 15, No 6 (2023) | Neuromyelitis optica spectrum disorders and complement system: issues of pathogenesis and therapeutic options | Abstract similar documents |
| V. S. Krasnov | ||
| "... ) with antibodies to aquaporin-4 (AQP4-IgG) is a classical pathway of complement system (CS) activation ..." | ||
| Vol 16, No 6 (2024) | Neuromyelitis optica spectrum disorders, terminology and therapeutic issues: amended consensus opinion | Abstract similar documents |
| V. S. Krasnov, Yu. V. Vlasov, E. P. Evdoshenko, D. S. Korobko, M. D. Matson, A. I. Nilov, A. A. Sokolova, N. A. Totolian, N. V Khachanova, M. V. Shumilina, M. V. Davydovskaya | ||
| "... with antibodies to aquaporin-4 (AQP4-IgG). The publication is intended to present the results of the work ..." | ||
| Vol 14, No 6 (2022) | Consensus opinion on the management of patients with neuromyelitis optica spectrum diseases: issues of terminology and therapy | Abstract similar documents |
| V. S. Krasnov, K. Z. Bakhtiyarova, E. P. Evdoshenko, D. S. Korobko, T. O. Simaniv, N. A. Totolyan, N. V. Khachanova, M. V. Shumilina, M. V. Davydovskaya | ||
| "... a therapeutic algorithm to prevent exacerbations in patients with NMOSD with serum IgG antibodies to aquaporin-4 ..." | ||
| Vol 15 (2023): (Suppl. 1) | Neuromyelitis optic spectrum disorders (NMOSD): from pathogenesis to targeted therapy | Abstract similar documents |
| P. A. Zaitseva, A. N. Boyko | ||
| "... optic spectrum disorders (NMOSD) associated with the appearance of anti-aquaporin-4 (APQ4-IgG ..." | ||
| Vol 15, No 5 (2023) | The role of cellular immunity and systemic inflammation indices in the pathogenetic mechanisms of mental disorders | Abstract similar documents |
| A. P. Gorbunova, G. V. Rukavishnikov, E. D. Kasyanov, G. E. Mazo | ||
| "... ) are already used in somatic specialties: neutrophil-lymphocyte (NLR), monocyte-lymphocyte (MLR) and platelet ..." | ||
| Vol 10, No 1 (2018) | Neuromyelitis optica spectrum disorders in pediatric patients | Abstract similar documents |
| Yu. V. Tokareva, A. S. Kotov, M. V. Panteleeva, M. S. Bunak | ||
| "... of neuromyelitis optica ((NMO)-IgG autoantibodies against the cell membrane water channel protein aquaporin 4 (AQP4 ..." | ||
| Vol 15 (2023): (Suppl. 1) | Delayed diagnosis of the neuromyelitis optica spectrum disorder | Abstract similar documents |
| S. A. Dzhukkaeva, E. V. Ermilova, Sh. R. Nabiev, O. N. Voskresenskaya | ||
| "... criteria for NMOSD. The majority of patients with NMOSD have aquaporin-4 autoantibody (AQP4-IgG). This case ..." | ||
| Vol 16 (2024): (Suppl. 2) | High-dose immunosuppressive therapy followed by haematopoietic stem cell transplantation as a method for the treatment of refractory forms of neuromyelitis optica spectrum disorder in children | Abstract similar documents |
| N. N. Bronina, O. V. Bykova, G. O. Bronin, A. E. Kessel, G. Z. Seregin, K. I. Kirgizov, A. Yu. Polushin, T. T. Batysheva | ||
| "... immunoglobulin G, AQP4-IgG), less commonly with class G antibodies against the glycoprotein of myelin ..." | ||
| Vol 8, No 3 (2016) | Longitudinally extensive transverse myelitis associated with intrathecal synthesis of oligoclonal immunoglobulin G and with vitamin B12 deficiency | Abstract similar documents |
| V. S. Krasnov, A. S. Bedenko, N. A. Totolyan, A. A. Skoromets | ||
| "... strokes also revealed the reduced levels of vitamin B12 in serum and oligoclonal IgG in cerebrospinal ..." | ||
| Vol 13, No 5 (2021) | Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders | Abstract PDF (Eng) similar documents |
| A. N. Boyko, K. Z. Bakhtiyarova, L. V. Brylev, M. N. Zakharova, D. S. Kasatkin, D. S. Korobko, S. V. Kotov, V. S. Krasnov, N. A. Malkova, E. V. Popova, S. A. Sivertseva, T. O. Simaniv, A. A. Sokolova, N. A. Totolyan, T. N. Trushnikova, F. A. Khabirov, N. V. Khachanova | ||
| "... diagnostic program including the aquaporin-4 antibodies (AQP4-IgG) testing; to evaluate the implementation ..." | ||
| Vol 13, No 2 (2021) | Acute sensory inflammatory demyelinating polyneuropathy and central diabetes insipidus | Abstract similar documents |
| T. G. Sakovets, E. I. Bogdanov | ||
| "... of arthralgias, accompanied by a low-grade fever and a single positive denatured DNA IgG antibodies test ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical presentation and course of multiple sclerosis in patients with herpesvirus infection | Abstract similar documents |
| M. S. Gris, N. S. Baranova, N. N. Spirin, D. S. Kasatkin, D. V. Kiselev, E. G. Shipova | ||
| "... included in the control group. Serum levels of type-specific IgM and IgG antibodies to herpes simplex virus ..." | ||
| Vol 6, No 3 (2014) | Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis | Abstract similar documents |
| S. M. Karpov, Z. B. Pazhigova, E. N. Karpova | ||
| "... established higher levels of IgG antibodies against myelin basic protein. The most significant latency ..." | ||
| 1 - 24 of 24 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
